Atricure Inc. buy UBS Group AG
Start price
30.10.24
/
50%
€29.29
Target price
30.10.25
€36.85
Performance (%)
3.79%
End price
31.10.25
€30.40
Summary
This prediction ended on 31.10.25 with a price of €30.40. With a performance of 3.79%, the BUY prediction by UBS_Group_AG for Atricure Inc. closed with a slight gain. UBS_Group_AG has a follow-up prediction for Atricure Inc. where he still thinks Atricure Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | 2.941% | 2.941% | -43.548% |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten